Delivery of 10boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy

Oral Oncology

Volumn 40, Issue 5, 2004, Pages 474-482

  Obayashi, Shigeki ^a   Kato, Itsuro ^a   Ono, Koji ^b   Masunaga, Shin Ichiro ^b   Suzuki, Minoru ^b   Nagata, Kenji ^b   Sakurai, Yoshinori ^b   Yura, Yoshiaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Boron concentration; Boron neutron capture therapy; Oral squamous cell carcinoma; Surviving cell fraction

Indexed keywords

4 BORONOPHENYLALANINE B 10; BOROCAPTATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CELL SURVIVAL; COLONY FORMATION; DRUG BLOOD LEVEL; DRUG BONE LEVEL; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; FEMALE; MOUSE; MOUTH CARCINOMA; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SKIN; SQUAMOUS CELL CARCINOMA; THERMAL EXPOSURE;

ANIMALS; BOROHYDRIDES; BORON; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; ISOTOPES; MICE; MICE, NUDE; MOUTH NEOPLASMS; PHENYLALANINE; RELATIVE BIOLOGICAL EFFECTIVENESS; SULFHYDRYL COMPOUNDS;

EID: 1542360071     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.09.018     Document Type: Article

References (31)

1. Slatkin D.N. A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit. Brain. 114:1991;1609-1629.
2. Barth R., Soloway A.H., Fairchild R.G., Brugger R.M. Boron neutron capture therapy for cancer. Realities and prospects. Cancer. 70:1992;2995-3007.
3. 10B-compound. Lancet. 12:1989;388-389.
4. Hatanaka H., Nakagawa Y. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;1061-1066.
5. Coderre J.A., Morris G.M., Micca P.L., Fisher C.D., Ross G.A. Comparative assessment of single-dose and fractionated boron neutron capture therapy. Radiat. Res. 144:1995;310-317.
6. Coderre J.A., Elowitz E.H., Chadha M., Bergland R., Capala J., Joel D.D.et al. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results. J. Neurooncol. 33:1997;141-152.
7. Chadha M., Capala J., Coderre J.A., Elowitz E.H., Iwai J., Joel D.D.et al. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;829-834.
8. Khuri F.R., Lippman S.M., Spitz M.R., Lotan R., Hong W.K. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J. Natl. Cancer Inst. 89:1997;199-211.
9. Smith B.D., Haffty B.G. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiat. Oncol. Invest. 7:1999;125-144.
10. Fu K.K., Cooper J.S., Marcial V.A., Laramore G.E., Pajak T.F., Jacobs J.et al. Evolution of the radiation therapy oncology group clinical trials for head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;425-438.
11. Kastenbauer E., Wollenberg B. In search of new treatment methods for head-neck carcinoma. Laryngorhinootologie. 78:1999;31-35.
12. Coderre J.A., Morris G.M. The radiation biology of boron neutron capture therapy. Radiat. Res. 151:1999;1-18.
13. Fairchild R.G. "Epithermal" neutron beam isodate charts in a phantom head. Radiology. 85:1965;555-564.
14. Moss R.L., Aizawa O., Beynon D., Brugger R., Constantine G., Harling O. et al. The requirements and development of neutron beams for neutron capture therapy of brain cancer. J. Neurooncol. 33:1997;27-40.
15. Kreimann E.L., Itoiz M.E., Longhino J., Blaumann H., Calzetta O., Schwint A.E. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model. Cancer Res. 61:2001;8638-8642.
16. Kreimann E.L., Itoiz M.E., Dagrosa A., Garavaglia R., Farias S., Batistoni D.et al. The hamster cheek pouch as a model of oral cancer boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Cancer Res. 61:2001;8775-8781.
17. Ono K., Masunaga S., Kinashi Y., Takagaki M., Akaboshi M., Kobayashi T. et al. Radiobiological evidence suggesting heterogenous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 34:1996;1081-1086.
18. 10B-BSH) in neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 42:1998;823-826.
19. Yanagie H., Tomita T., Kobayashi H., Fujii Y., Nonaka Y., Saegusa Y.et al. Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy. Br. J. Cancer. 75:1997;660-665.
20. 10B-L-borophenylalanine for boron neutron capture therapy. Br. J. Radiol. 71:1998;320-323.
21. Ono K., Masunaga S., Suzuki M., Kinashi Y., Takagaki M., Akaboshi M. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice. Int. J. Radiat. Oncol. Biol. Phys. 43:1999;431-436.
22. Miura M., Morris G.M., Micca P.L., Lombardo D.T., Youngs K.M., Kalef-Ezra J.A.et al. Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin. Radiat. Res. 155:2001;603-610.
23. Dagrosa M.A., Viaggi M., Kreimann E., Farias S., Garavaglia R., Agote M.et al. Selective uptake of p-boronophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy. Thyroid. 12:2002;7-12.
24. Hasina R., Matsumoto K., Matsumoto-Taniura N., Kato I., Sakuda M., Nakamura T. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line. Br. J. Cancer. 80:1999;1708-1717.
25. 10B concentration in tissue for neutron capture therapy by prompt gamma-ray spectrometry. Nucl. Instrum. Methods. 204:1982;525-531.
26. Kinashi Y., Sakurai Y., Masunaga S., Takagaki M., Ono K. Sensitizing effect of the phosphatidylinositol 3-kinase inhibitor wortmannin on thermal neutron irradiation with or without boron compound. Radiat. Med. 19:2001;27-32.
27. Suzuki M., Masunaga Si, Kinashi Y., Takagaki M., Sakurai Y., Kobayashi T.et al. The effects of boron neutron capture therapy on liver tumors and normal hepatocytes in mice. Jpn. J. Cancer Res. 91:2000;1058-1064.
28. Chanana A.D., Capala J., Chadha M., Coderre J.A., Diaz A.Z., Elowitz E.H.et al. Boron neutron capture therapy for glioblastoma multiforme: interim results from the phase I/II dose-escalation studies. Neurosurgery. 44:1999;1182-1193.
29. Coderre J.A., Glass J.D., Fairchild R.G., Roy U., Cohen S., Fand I. Selective targeting of boronophenylalanine to melanoma for neutron capture therapy. Cancer Res. 47:1987;6377-6383.
30. Coderre J.A., Morris G.M., Kalef-Ezra J., Micca P.L., Ma R., Youngs K.et al. The effects of boron neutron capture irradiation on oral mucosa: evaluation using a rat tongue model. Radiat. Res. 152:1999;113-118.
31. Fairchild R.G., Slatkin D.N., Coderre J.A., Micca P.L., Laster B.H., Kahl S.B.et al. Optimization of boron and neuron delivery for neutron capture therapy. Pig Cell Res. 2:1989;309-318.